Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
Giuseppe TarantiniMarco MojoliGiulia MasieroBernardo CorteseBruno LoiAttilio VarricchioGabriele GabrielliAlessandro DuranteGiampaolo PasquettoPaolo CalabròRoberto GistriGabriele TumminelloLeonardo MisuracaFrancesco PisanoAlfonso IelasiPietro MazzarottoSebastian CoscarelliValerio LucciLuciano MorettiAnnamaria NicolinoAlessandro ColomboZoran OlivariMassimo FineschiDavide PirainoLuigi PiattiUmberto CanosiPaola TellaroliDonatella CorradoChiara RoveraGiuseppe Steffeninonull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
Outcomes of patients with or without overlapping BVS were comparable at mid-term follow-up despite higher angiographic complexity of the overlap subset. © 2017 Wiley Periodicals, Inc.